USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Areva NC

USPTO PatentsView assignee record — 26 granted patents across 35 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G21F (PROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR).

26
Total patents granted
35
CPC technology areas
17.8
Avg claims per patent
-92%
5-year filing velocity

Portfolio overview

Areva NC has been granted 26 US utility patents between 2015 and 2022, placing Areva NC at rank #11,555 across all assignees tracked by PlainPatent. This portfolio spans 35 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.8 claims per patent with primary concentration in G21F (PROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR). As a Foreign Corporation, Areva NC is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 56.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 24 in the 2015–2019 window — a -92% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Areva NC's 17.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 35 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Areva NC against peers pursuing similar technology classes.

How does Areva compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Areva holds 26 patents — placing it at rank #11,555 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2022

051015 20152016201720182022 2
USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Areva NC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 12 46.2%
2016 3 11.5%
2017 7 26.9%
2018 2 7.7%
2022 2 7.7%

Which technologies does Areva NC patent most?

Top 15 of 35 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#11,555

Across all tracked assignees

Innovation Score

56.3 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Areva NC hold?
Areva NC holds 26 US granted patents filed between 2015 and 2022, spanning 35 technology areas.
What is Areva NC's Innovation Score?
Areva NC has an Innovation Score of 56.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Areva NC focus on?
Areva NC's top technology area is G21F (PROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR) with 11 patents. The company has filed patents in 35 CPC subclasses total.
Is Areva NC's patent filing rate increasing or decreasing?
Areva NC's recent filing velocity is -92% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Areva NC's patents?
Areva NC's patents average 17.8 claims each. This falls within the standard range, providing solid legal coverage.
How is the Areva NC patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope